CA125 reduction as a potential predictive marker of radiological response to neoadjuvant chemotherapy in advanced unresectable endometrial cancer
Year: 2027
Type: article
Abstract: Objective Neoadjuvant chemotherapy (NACT) followed by interval cytoreductive surgery is increasingly used in advanced endometrial cancer patients not amenable for primary surgery. However, validated biomarkers to predict treatment response and surgical outcomes remain lacking.
Source: Journal of Gynecologic Oncology
Language: English
Subfield: Obstetrics and Gynecology
Field: Medicine
Domain: Health Sciences
Open Access status: diamond
OpenAlex ID: W7236463408
